1. Dose escalation methods in phase I cancer clinical trials;C Le Tourneau;J Natl Cancer Inst,2009
2. Translation of innovative designs into phase I trials;A Rogatko;J Clin Oncol,2007
3. A comprehensive comparison of the continual reassessment method to the standard 3+3 dose escalation scheme in phase I dose-finding studies;A Iasonos;Clin Trials,2008
4. Dose escalation methodology in phase I clinical trials: a comparison of the modified continual reassessment method (MCRM) and a traditional method. Experience with the multitargeted antifolate (MTA);J Walling;Proc Am Soc Clin Oncol,1997
5. The continual reassessment method (CRM) for dose escalation in phase I trials in San Antonio does not result in more rapid study completion;SG Eckhardt;Proc Am Soc Clin Oncol,1999